Aims This paper provides a concise review of the efficacy, effectiveness and affordability of
health‐care interventions to promote and assist tobacco cessation, in order to inform …

Aims To assess (1) how far the efficacies of front‐line smoking cessation pharmacotherapies
vary as a function of smoker characteristics and (2) associations between these …

The endogenous cannabinoid anandamide (AEA) exerts the majority of its effects at CB1
and CB2 receptors and is degraded by fatty acid amide hydrolase (FAAH). FAAH KO mice …

OBJECTIVE: Smoking prevalence is frequently estimated on the basis of self-reported
smoking status. That can lead to an underestimation of smoking rates. The aim of this study …

Background Meta-analyses of clinical trial data have identified clinically relevant gender
differences in the efficacy of smoking cessation pharmacotherapy. It is unclear whether …

Background Smokers present a higher prevalence and severity of periodontitis and,
consequently, higher prevalence of tooth loss. Smoking cessation improves the response to …

Objectives: Using a participatory research approach, this study reports the efficacy of the
Communities Engaged and Advocating for a Smoke-free Environment (CEASE)-4 …

Smoking disproportionally affects minority and underserved populations but only a handful
of interventions tailored to these populations have demonstrated effectiveness in real-life …

For the past 30 years, research examining predictors of successful smoking cessation
treatment response has focused primarily on clinical variables, such as levels of tobacco …

Nicotine, the primary psychoactive component in tobacco, plays a major role in the initiation
and maintenance of tobacco dependence and addiction, a leading cause of preventable …